The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified.

Apogee Therapeutics, Inc.

Spyre Therapeutics, Inc.

Oruka Therapeutics, Inc.

Moderna, Inc.

Kymera Therapeutics, Inc.

Praxis Precision Medicines, Inc.

Twist Bioscience Corporation

CG Oncology Inc.

Beam Therapeutics Inc.

Rhythm Pharmaceuticals, Inc.

Healthcare

Financial Services

Direxion Daily S&P Biotech Bull 3X Shares

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF is an exchange traded fund launched by Direxion Investments. It is managed by Rafferty Asset Management, LLC. It invests in public equity markets of the United States. It invests directly, through derivatives and through other funds in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. It uses derivatives such as futures, swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track 3x the daily performance of the S&P Biotechnology Select Industry Index. Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF was formed on May 28, 2015 and is domiciled in the United States.

LABU Holdings & Sector Breakdown

LABU Holdings & Sector Breakdown